Statistical considerations for some studies of over-the-counter drugs

被引:1
作者
Lin, Stan C. [1 ]
机构
[1] US FDA, Div Biometr 4, Off Biostat, Ctr Drug Evaluat & Res, Silver Spring, MD USA
来源
DRUG INFORMATION JOURNAL | 2007年 / 41卷 / 04期
关键词
over-the-counter drugs; label comprehension and actual use studies; confidence intervals; sample size; variance estimate;
D O I
10.1177/009286150704100409
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In this article, the label comprehension and actual use studies that may be required for an over-the-counter new drug regulatory submission are introduced. Design for these studies and statistical issues are described. Because confidence interval is a tool that plays a central role in these studies, information needed and appropriate sample size estimation approaches are discussed. Carefully designed and analyzed studies would enhance their success rate and provide more useful information from the studies.
引用
收藏
页码:511 / 516
页数:6
相关论文
共 50 条
  • [21] Over-the-Counter Drugs: Regulatory Analysis of Warning Letters Between Fiscal Years 2015–2019
    Helen K. Bai
    Jennifer D. Ahearn
    Michael G. Bartlett
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 426 - 436
  • [22] Over-the-counter analgesics and antipyretics: A critical assessment
    Hersh, EV
    Moore, P
    Ross, GL
    CLINICAL THERAPEUTICS, 2000, 22 (05) : 500 - 548
  • [23] Prescription to over-the-counter switches in the United States
    Chang, Jongwha
    Lizer, Allison
    Patel, Isha
    Bhatia, Deepak
    Tan, Xi
    Balkrishnan, Rajesh
    JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2016, 5 (03) : 149 - 154
  • [24] Societal perspectives on over-the-counter (OTC) medicines
    Wazaify, M
    Shields, E
    Hughes, CM
    McElnay, JC
    FAMILY PRACTICE, 2005, 22 (02) : 170 - 176
  • [25] Dangerous Double Dosing: How Naive Beliefs Can Contribute to Unintentional Overdose with Over-the-Counter Drugs
    Catlin, Jesse R.
    Pechmann, Cornelia
    Brass, Eric P.
    JOURNAL OF PUBLIC POLICY & MARKETING, 2015, 34 (02) : 194 - 209
  • [26] Exploiting the Potential Value of Over-the-counter Drugs Through Brand Equity: An Analytic Network Process Approach
    Battistoni, Elisa
    Colladon, Andrea Fronzetti
    Puglia, Paolo
    INTERNATIONAL JOURNAL OF ENGINEERING BUSINESS MANAGEMENT, 2014, 6 : 1 - 9
  • [27] Over-the-Counter Drugs: Regulatory Analysis of Warning Letters Between Fiscal Years 2015-2019
    Bai, Helen K.
    Ahearn, Jennifer D.
    Bartlett, Michael G.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (02) : 426 - 436
  • [28] Knowledge and Use of Over-the-counter Drugs in Italy: An Exploratory Survey-based Study in the General Population
    Chiappini, Stefania
    Ceci, Franca
    Mosca, Alessio
    Di Carlo, Francesco
    Burkauskas, Julius
    Pettorruso, Mauro
    Martinotti, Giovanni
    Guirguis, Amira
    Corkery, John M. M.
    Scherbaum, Norbert
    Schifano, Fabrizio
    Di Giannantonio, Massimo
    CURRENT NEUROPHARMACOLOGY, 2023, 21 (01) : 133 - 141
  • [29] Unprescribed and unnoticed: Retrospective chart review of adverse events of interactions between antidepressants and over-the-counter drugs
    Woron, Jaroslaw
    Chrobak, Adrian Andrzej
    Slezak, Daniel
    Siwek, Marcin
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [30] Over-the-Counter Monograph Safety, Innovation, and Reform Act
    Gardiner, Jason
    Kesselheim, Aaron S.
    JOURNAL OF LAW MEDICINE & ETHICS, 2021, 49 (02) : 321 - 327